Very proud of mentoring these two exceptional and gifted early-career scientists! @FahriyeDuzagac and @AnaMBolivarA #VilarLab #WomenInSTEM

Excited to share our findings on immune tolerance and prevention of cancer progression in #Lynch syndrome and our neoantigen discovery/validation efforts with @AnaMBolivarA at the @IOTNmoonshot SC meeting. I also humbled to receive the early career scientist presenter award.

FahriyeDuzagac's tweet image. Excited to share our findings on immune tolerance and prevention of cancer progression in #Lynch syndrome and our neoantigen discovery/validation efforts with @AnaMBolivarA at the @IOTNmoonshot  SC meeting.  I also humbled to receive the early career scientist presenter award.
FahriyeDuzagac's tweet image. Excited to share our findings on immune tolerance and prevention of cancer progression in #Lynch syndrome and our neoantigen discovery/validation efforts with @AnaMBolivarA at the @IOTNmoonshot  SC meeting.  I also humbled to receive the early career scientist presenter award.
FahriyeDuzagac's tweet image. Excited to share our findings on immune tolerance and prevention of cancer progression in #Lynch syndrome and our neoantigen discovery/validation efforts with @AnaMBolivarA at the @IOTNmoonshot  SC meeting.  I also humbled to receive the early career scientist presenter award.


📢 📑Hot off the press from the #VilarLab in @PlosGenetics 'A comprehensive analysis of a spontaneous non-human primate model of #LynchSyndrome CRC' A collab w The Michael Keeling Center at @MDAndersonNews and the #RogersLab of @thelabsofBCM. Read 🧵below w @Charles_M_Bowen 1/8

evilarsan's tweet image. 📢 📑Hot off the press from the #VilarLab in @PlosGenetics 'A comprehensive analysis of a spontaneous non-human primate model of #LynchSyndrome CRC' A collab w The Michael Keeling Center at @MDAndersonNews and the #RogersLab of @thelabsofBCM. Read 🧵below w @Charles_M_Bowen 1/8

🥁Got the results of the R01 yesterday and I decided to wait and log in again today to be sure that I was not dreaming! Awesome 💥 job of the entire #VilarLab @Charles_M_Bowen @AnaMBolivarA @laurareyesuribe @FahriyeDuzagac Krishna Sinha

evilarsan's tweet image. 🥁Got the results of the R01 yesterday and I decided to wait and log in again today to be sure that I was not dreaming! Awesome 💥 job of the entire #VilarLab @Charles_M_Bowen @AnaMBolivarA @laurareyesuribe @FahriyeDuzagac Krishna Sinha

📰#VilarLab #JournalClub Re-visiting the great work of @cristomasetti very interesting results on the application of this model to #LynchSyndrome cumulative #cancer #risk pnas.org/content/117/2/…

evilarsan's tweet image. 📰#VilarLab #JournalClub Re-visiting the great work of @cristomasetti very interesting results on the application of this model to #LynchSyndrome cumulative #cancer #risk pnas.org/content/117/2/…
evilarsan's tweet image. 📰#VilarLab #JournalClub Re-visiting the great work of @cristomasetti very interesting results on the application of this model to #LynchSyndrome cumulative #cancer #risk pnas.org/content/117/2/…

MD Anderson is again #1 in the nation for cancer care in @USNews’ “Best Hospitals” ranking: bit.ly/3Oh6k4v Thanks to all who make this possible: our faculty, employees, trainees, students, volunteers, donors, advocates, partners, patients and caregivers. #BestHospitals

UTMDAnderson's tweet image. MD Anderson is again #1 in the nation for cancer care in @USNews’ “Best Hospitals” ranking: bit.ly/3Oh6k4v

Thanks to all who make this possible: our faculty, employees, trainees, students, volunteers, donors, advocates, partners, patients and caregivers.  #BestHospitals


#VilarLab #JournalClub Today @MikaylaMDPhD from the Yates Lab presents a very interesting paper on single-cell sequencing of normal physiologic endometrium doi.org/10.1038/s41591… @kchenken @KColbertMPH

evilarsan's tweet image. #VilarLab #JournalClub Today @MikaylaMDPhD from the Yates Lab presents a very interesting paper on single-cell sequencing of normal physiologic endometrium doi.org/10.1038/s41591… @kchenken @KColbertMPH

Boom!! Way to go #vilarlab @MDAndersonNews. Honored to be a part of this group and learn the art of translational cancer research!

🥁Got the results of the R01 yesterday and I decided to wait and log in again today to be sure that I was not dreaming! Awesome 💥 job of the entire #VilarLab @Charles_M_Bowen @AnaMBolivarA @laurareyesuribe @FahriyeDuzagac Krishna Sinha

evilarsan's tweet image. 🥁Got the results of the R01 yesterday and I decided to wait and log in again today to be sure that I was not dreaming! Awesome 💥 job of the entire #VilarLab @Charles_M_Bowen @AnaMBolivarA @laurareyesuribe @FahriyeDuzagac Krishna Sinha


Made it to the #2023jointmeeting@the_asci⁩ to present our IMC work ⁦@MDAndersonNews⁩. Was a wild day of travel. Did not arrive until 4 am, and ⁦@SouthwestAir⁩ lost our bags (look who dressed appropriately on the flight 🫣) #vilarlab

Charles_M_Bowen's tweet image. Made it to the #2023jointmeeting ⁦@the_asci⁩  to present our IMC work ⁦@MDAndersonNews⁩. Was a wild day of travel. Did not arrive until 4 am, and ⁦@SouthwestAir⁩ lost our bags (look who dressed appropriately on the flight 🫣) #vilarlab

📣: Hot off the press: Now out in the #LynchSyndrome community, we expand our knowledge from the 'Naproxen Trial' by discovering that daily naproxen maintains proliferation of CD8 T cells in colorectal mucosa. #VilarLab @evilarsan @MDAndersonNews

New Research: Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa: Background Recent clinical trial data from Lynch Syndrome (LS) carriers demonstrated that naproxen administered for… #immunology frontiersin.org/articles/10.33…



Coming soon to a journal near you! Great work from the #vilarlab @MDAndersonNews

Great wrap-up at #AACR24! Big thanks to all who joined us to explore immune interception strategies for Lynch-related colorectal cancer via EZH2 inhibition. #CancerPrevention #EZH2 #LynchSyndrome #Vilarlab

FahriyeDuzagac's tweet image. Great wrap-up at #AACR24!  Big thanks to all who joined us to explore immune interception strategies for Lynch-related colorectal cancer via EZH2 inhibition. #CancerPrevention #EZH2 #LynchSyndrome #Vilarlab
FahriyeDuzagac's tweet image. Great wrap-up at #AACR24!  Big thanks to all who joined us to explore immune interception strategies for Lynch-related colorectal cancer via EZH2 inhibition. #CancerPrevention #EZH2 #LynchSyndrome #Vilarlab


📢 The #VilarLab is hiring! We are looking for motivated post-doctoral fellows to join us. Are you interested in #HereditaryCancers #LynchSyndrome #DNARepair #Genomics❓Interested candidates DM me Here is the ref to the position #600709-202202070944 mdanderson.org/about-md-ander…


💥Very proud of this pub and the exceptional team work #VilarLab @koolmolecule @Charles_M_Bowen @laurareyesuribe @zozcan89 @DrJasonWillis @pascheet Krishna Sinha Looking forward to our presentation on Friday at @MDAndersonNews Research Town Hall #LynchSyndrome #Genetics #CRC

Bommi et al report that expression signatures of DNA mismatch repair-deficient intestinal #StemCells recapitulate the initial steps of #LynchSyndrome carcinogenesis. @Koolmolecule @Charles_M_Bowen laurareyesu @zozcan89 DrJasonWillis @evilarsan bit.ly/2POePZW

CR_AACR's tweet image. Bommi et al report that expression signatures of DNA mismatch repair-deficient intestinal #StemCells recapitulate the initial steps of #LynchSyndrome carcinogenesis. @Koolmolecule @Charles_M_Bowen laurareyesu @zozcan89 DrJasonWillis @evilarsan 
bit.ly/2POePZW


📚#VilarLab #JournalClub Today Nejla Lermi Ozirmak is presenting the work from @VeroushkaBalle1 @DrJohnKisiel @FASinicropeMD Very promising data for development of future early diagnostic tools in #LynchSyndrome pubmed.ncbi.nlm.nih.gov/33350853/

evilarsan's tweet image. 📚#VilarLab #JournalClub Today Nejla Lermi Ozirmak is presenting the work from @VeroushkaBalle1 @DrJohnKisiel @FASinicropeMD Very promising data for development of future early diagnostic tools in #LynchSyndrome pubmed.ncbi.nlm.nih.gov/33350853/

Amazing presentation of 💪 computational work 💻 by @cemdede for his PhD rotation @MDA_UTHGrad in the #VilarLab Methylome analysis in #Lynchsyndrome patients It has been a pleasure to host you and we hope that you come BACK!

evilarsan's tweet image. Amazing presentation of 💪 computational work 💻 by @cemdede for his PhD rotation @MDA_UTHGrad in the #VilarLab Methylome analysis in #Lynchsyndrome patients It has been a pleasure to host you and we hope that you come BACK!

Excited for #SITC2022 in Boston! Presenting my poster on Fri on work w @AnaMBolivarA @laurareyesuribe as #Vilarlab @evilarsan. Say hi @ Poster 28, Identification and Functional Validation of Neoantigens-Specific T-Cell Receptors in Lynch Syndrome  and Poster 36. Thx @sitcancer


🎉Congrats @AnaMBolivarA #VilarLab member for passing your PhD candidacy exam today! You are doing really cool science 🧪 #LynchSyndrome So happy to tag along in your journey @MDA_UTHGrad 🙏 to committee members @Aiims1742 @karenluMD @IamLinghua @AReubenPhD Jim Hixson!


Coming soon to a journal near you! Great work from the #vilarlab @MDAndersonNews

Great wrap-up at #AACR24! Big thanks to all who joined us to explore immune interception strategies for Lynch-related colorectal cancer via EZH2 inhibition. #CancerPrevention #EZH2 #LynchSyndrome #Vilarlab

FahriyeDuzagac's tweet image. Great wrap-up at #AACR24!  Big thanks to all who joined us to explore immune interception strategies for Lynch-related colorectal cancer via EZH2 inhibition. #CancerPrevention #EZH2 #LynchSyndrome #Vilarlab
FahriyeDuzagac's tweet image. Great wrap-up at #AACR24!  Big thanks to all who joined us to explore immune interception strategies for Lynch-related colorectal cancer via EZH2 inhibition. #CancerPrevention #EZH2 #LynchSyndrome #Vilarlab


MD Anderson is again #1 in the nation for cancer care in @USNews’ “Best Hospitals” ranking: bit.ly/3Oh6k4v Thanks to all who make this possible: our faculty, employees, trainees, students, volunteers, donors, advocates, partners, patients and caregivers. #BestHospitals

UTMDAnderson's tweet image. MD Anderson is again #1 in the nation for cancer care in @USNews’ “Best Hospitals” ranking: bit.ly/3Oh6k4v

Thanks to all who make this possible: our faculty, employees, trainees, students, volunteers, donors, advocates, partners, patients and caregivers.  #BestHospitals


Very proud of mentoring these two exceptional and gifted early-career scientists! @FahriyeDuzagac and @AnaMBolivarA #VilarLab #WomenInSTEM

Excited to share our findings on immune tolerance and prevention of cancer progression in #Lynch syndrome and our neoantigen discovery/validation efforts with @AnaMBolivarA at the @IOTNmoonshot SC meeting. I also humbled to receive the early career scientist presenter award.

FahriyeDuzagac's tweet image. Excited to share our findings on immune tolerance and prevention of cancer progression in #Lynch syndrome and our neoantigen discovery/validation efforts with @AnaMBolivarA at the @IOTNmoonshot  SC meeting.  I also humbled to receive the early career scientist presenter award.
FahriyeDuzagac's tweet image. Excited to share our findings on immune tolerance and prevention of cancer progression in #Lynch syndrome and our neoantigen discovery/validation efforts with @AnaMBolivarA at the @IOTNmoonshot  SC meeting.  I also humbled to receive the early career scientist presenter award.
FahriyeDuzagac's tweet image. Excited to share our findings on immune tolerance and prevention of cancer progression in #Lynch syndrome and our neoantigen discovery/validation efforts with @AnaMBolivarA at the @IOTNmoonshot  SC meeting.  I also humbled to receive the early career scientist presenter award.


📣: Hot off the press: Now out in the #LynchSyndrome community, we expand our knowledge from the 'Naproxen Trial' by discovering that daily naproxen maintains proliferation of CD8 T cells in colorectal mucosa. #VilarLab @evilarsan @MDAndersonNews

New Research: Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa: Background Recent clinical trial data from Lynch Syndrome (LS) carriers demonstrated that naproxen administered for… #immunology frontiersin.org/articles/10.33…



Made it to the #2023jointmeeting@the_asci⁩ to present our IMC work ⁦@MDAndersonNews⁩. Was a wild day of travel. Did not arrive until 4 am, and ⁦@SouthwestAir⁩ lost our bags (look who dressed appropriately on the flight 🫣) #vilarlab

Charles_M_Bowen's tweet image. Made it to the #2023jointmeeting ⁦@the_asci⁩  to present our IMC work ⁦@MDAndersonNews⁩. Was a wild day of travel. Did not arrive until 4 am, and ⁦@SouthwestAir⁩ lost our bags (look who dressed appropriately on the flight 🫣) #vilarlab

Come to see us @sitcancer poster #28 and poster #36 (or check out virtually) and let’s talk about our #neoantigen discovery and validation journey #Vilarlab @evilarsan @AnaMBolivarA @laurareyesuribe @AReubenPhD #Lynchsyndrome #SITC22

FahriyeDuzagac's tweet image. Come to see us @sitcancer poster #28 and poster #36 (or check out virtually) and let’s talk about our #neoantigen discovery and validation journey #Vilarlab @evilarsan @AnaMBolivarA @laurareyesuribe @AReubenPhD #Lynchsyndrome #SITC22

Excited for #SITC2022 in Boston! Presenting my poster on Fri on work w @AnaMBolivarA @laurareyesuribe as #Vilarlab @evilarsan. Say hi @ Poster 28, Identification and Functional Validation of Neoantigens-Specific T-Cell Receptors in Lynch Syndrome  and Poster 36. Thx @sitcancer


Welcome back to the #VilarLab Although you were never really gone 😁@Charles_M_Bowen What a team! @AnaMBolivarA @FahriyeDuzagac @laurareyesuribe Krishna Sinha Surendra Chaurasiya

Feels good to be “officially” Making Cancer History (again) ⁦@MDAndersonNews⁩. Thankful ⁦@evilarsan⁩ has brought me back to help push some science forward in my spare time. Please don’t mind ⁦@MikaylaMDPhD⁩ in the background 🤓

Charles_M_Bowen's tweet image. Feels good to be “officially” Making Cancer History (again) ⁦@MDAndersonNews⁩. Thankful ⁦@evilarsan⁩ has brought me back to help push some science forward in my spare time. Please don’t mind ⁦@MikaylaMDPhD⁩ in the background 🤓


📢 📑Hot off the press from the #VilarLab in @PlosGenetics 'A comprehensive analysis of a spontaneous non-human primate model of #LynchSyndrome CRC' A collab w The Michael Keeling Center at @MDAndersonNews and the #RogersLab of @thelabsofBCM. Read 🧵below w @Charles_M_Bowen 1/8

evilarsan's tweet image. 📢 📑Hot off the press from the #VilarLab in @PlosGenetics 'A comprehensive analysis of a spontaneous non-human primate model of #LynchSyndrome CRC' A collab w The Michael Keeling Center at @MDAndersonNews and the #RogersLab of @thelabsofBCM. Read 🧵below w @Charles_M_Bowen 1/8

📢 The #VilarLab is hiring! We are looking for motivated post-doctoral fellows to join us. Are you interested in #HereditaryCancers #LynchSyndrome #DNARepair #Genomics❓Interested candidates DM me Here is the ref to the position #600709-202202070944 mdanderson.org/about-md-ander…


Boom!! Way to go #vilarlab @MDAndersonNews. Honored to be a part of this group and learn the art of translational cancer research!

🥁Got the results of the R01 yesterday and I decided to wait and log in again today to be sure that I was not dreaming! Awesome 💥 job of the entire #VilarLab @Charles_M_Bowen @AnaMBolivarA @laurareyesuribe @FahriyeDuzagac Krishna Sinha

evilarsan's tweet image. 🥁Got the results of the R01 yesterday and I decided to wait and log in again today to be sure that I was not dreaming! Awesome 💥 job of the entire #VilarLab @Charles_M_Bowen @AnaMBolivarA @laurareyesuribe @FahriyeDuzagac Krishna Sinha


🥁Got the results of the R01 yesterday and I decided to wait and log in again today to be sure that I was not dreaming! Awesome 💥 job of the entire #VilarLab @Charles_M_Bowen @AnaMBolivarA @laurareyesuribe @FahriyeDuzagac Krishna Sinha

evilarsan's tweet image. 🥁Got the results of the R01 yesterday and I decided to wait and log in again today to be sure that I was not dreaming! Awesome 💥 job of the entire #VilarLab @Charles_M_Bowen @AnaMBolivarA @laurareyesuribe @FahriyeDuzagac Krishna Sinha

📢 The #VilarLab is hiring! Do you want to #EndCancer through Prevention? Do you want to help patients with #HereditaryGI Syndromes? We are looking for energetic #postdocs 2 join the team Position posted @MDAndersonNews website Req #: 600709-202202070944 Plz reach out w❓


I can’t wait to see what comes from this beautiful science! Way to go #vilarlab @MDAndersonNews


ไม่พบผลลัพธ์สำหรับ "#vilarlab"

Come to see us @sitcancer poster #28 and poster #36 (or check out virtually) and let’s talk about our #neoantigen discovery and validation journey #Vilarlab @evilarsan @AnaMBolivarA @laurareyesuribe @AReubenPhD #Lynchsyndrome #SITC22

FahriyeDuzagac's tweet image. Come to see us @sitcancer poster #28 and poster #36 (or check out virtually) and let’s talk about our #neoantigen discovery and validation journey #Vilarlab @evilarsan @AnaMBolivarA @laurareyesuribe @AReubenPhD #Lynchsyndrome #SITC22

#VilarLab Journal Club happening now led by @AnaMBolivarA Today reviewing key parameters for epitope immunogenicity Very important pub for all of us working with NeoAg and vaccines! sciencedirect.com/science/articl…

evilarsan's tweet image. #VilarLab Journal Club happening now led by @AnaMBolivarA Today reviewing key parameters for epitope immunogenicity Very important pub for all of us working with NeoAg and vaccines! sciencedirect.com/science/articl…

📰#VilarLab #JournalClub Re-visiting the great work of @cristomasetti very interesting results on the application of this model to #LynchSyndrome cumulative #cancer #risk pnas.org/content/117/2/…

evilarsan's tweet image. 📰#VilarLab #JournalClub Re-visiting the great work of @cristomasetti very interesting results on the application of this model to #LynchSyndrome cumulative #cancer #risk pnas.org/content/117/2/…
evilarsan's tweet image. 📰#VilarLab #JournalClub Re-visiting the great work of @cristomasetti very interesting results on the application of this model to #LynchSyndrome cumulative #cancer #risk pnas.org/content/117/2/…

Amazing presentation of 💪 computational work 💻 by @cemdede for his PhD rotation @MDA_UTHGrad in the #VilarLab Methylome analysis in #Lynchsyndrome patients It has been a pleasure to host you and we hope that you come BACK!

evilarsan's tweet image. Amazing presentation of 💪 computational work 💻 by @cemdede for his PhD rotation @MDA_UTHGrad in the #VilarLab Methylome analysis in #Lynchsyndrome patients It has been a pleasure to host you and we hope that you come BACK!

🥁Got the results of the R01 yesterday and I decided to wait and log in again today to be sure that I was not dreaming! Awesome 💥 job of the entire #VilarLab @Charles_M_Bowen @AnaMBolivarA @laurareyesuribe @FahriyeDuzagac Krishna Sinha

evilarsan's tweet image. 🥁Got the results of the R01 yesterday and I decided to wait and log in again today to be sure that I was not dreaming! Awesome 💥 job of the entire #VilarLab @Charles_M_Bowen @AnaMBolivarA @laurareyesuribe @FahriyeDuzagac Krishna Sinha

#VilarLab #JournalClub Today @MikaylaMDPhD from the Yates Lab presents a very interesting paper on single-cell sequencing of normal physiologic endometrium doi.org/10.1038/s41591… @kchenken @KColbertMPH

evilarsan's tweet image. #VilarLab #JournalClub Today @MikaylaMDPhD from the Yates Lab presents a very interesting paper on single-cell sequencing of normal physiologic endometrium doi.org/10.1038/s41591… @kchenken @KColbertMPH

📢 📑Hot off the press from the #VilarLab in @PlosGenetics 'A comprehensive analysis of a spontaneous non-human primate model of #LynchSyndrome CRC' A collab w The Michael Keeling Center at @MDAndersonNews and the #RogersLab of @thelabsofBCM. Read 🧵below w @Charles_M_Bowen 1/8

evilarsan's tweet image. 📢 📑Hot off the press from the #VilarLab in @PlosGenetics 'A comprehensive analysis of a spontaneous non-human primate model of #LynchSyndrome CRC' A collab w The Michael Keeling Center at @MDAndersonNews and the #RogersLab of @thelabsofBCM. Read 🧵below w @Charles_M_Bowen 1/8

How’s this for #WorkFromHome? #VilarLab journal club led by @Charles_M_Bowen. I’m playing dual role as captive audience and pet-herder.

MikaylaMDPhD's tweet image. How’s this for #WorkFromHome? #VilarLab journal club led by @Charles_M_Bowen. I’m playing dual role as captive audience and pet-herder.

Terrific joint lab meeting today between the #VilarLab and the #YatesLab Great opportunity to interact and learn more about #endometrial biology #stemcells #organoids Thanks @MikaylaMDPhD for the presentation @AnaMBolivarA @cemdede

evilarsan's tweet image. Terrific joint lab meeting today between the #VilarLab and the #YatesLab Great opportunity to interact and learn more about #endometrial biology #stemcells #organoids Thanks @MikaylaMDPhD for the presentation @AnaMBolivarA @cemdede

Made it to the #2023jointmeeting@the_asci⁩ to present our IMC work ⁦@MDAndersonNews⁩. Was a wild day of travel. Did not arrive until 4 am, and ⁦@SouthwestAir⁩ lost our bags (look who dressed appropriately on the flight 🫣) #vilarlab

Charles_M_Bowen's tweet image. Made it to the #2023jointmeeting ⁦@the_asci⁩  to present our IMC work ⁦@MDAndersonNews⁩. Was a wild day of travel. Did not arrive until 4 am, and ⁦@SouthwestAir⁩ lost our bags (look who dressed appropriately on the flight 🫣) #vilarlab

#VilarLab We just kicked off our Fall #JournalClub with a very cool paper @nussenza @BassLab_DFCI on WRN helicase dependency in MSI-H cancers. Presented by @Charles_M_Bowen nature.com/articles/s4158…

evilarsan's tweet image. #VilarLab We just kicked off our Fall #JournalClub with a very cool paper @nussenza @BassLab_DFCI on WRN helicase dependency in MSI-H cancers. Presented by @Charles_M_Bowen 
nature.com/articles/s4158…

📖#VilarLab #JournalClub Amazing work by @owen_sansom lab - SLC7A5 as an essential component in KRAS-driven carcinogenesis #CRC New potential avenue for treatment of #CMS3 subtypes Great and didactic presentation by @Charles_M_Bowen

evilarsan's tweet image. 📖#VilarLab #JournalClub Amazing work by @owen_sansom lab - SLC7A5 as an essential component in KRAS-driven carcinogenesis #CRC New potential avenue for treatment of #CMS3 subtypes Great and didactic presentation by @Charles_M_Bowen
evilarsan's tweet image. 📖#VilarLab #JournalClub Amazing work by @owen_sansom lab - SLC7A5 as an essential component in KRAS-driven carcinogenesis #CRC New potential avenue for treatment of #CMS3 subtypes Great and didactic presentation by @Charles_M_Bowen

#VilarLab #JournalClub Krishna Sinha reviewing the work of Vladimir Roudko @CimenBozkus_C from #bhardwajlab on shared neoAg from fs mutations in #MSIH #colorectalcancer Fantastic computational work along with in vitro validation doi.org/10.1016/j.cell…

evilarsan's tweet image. #VilarLab #JournalClub Krishna Sinha reviewing the work of Vladimir Roudko @CimenBozkus_C from #bhardwajlab on shared neoAg from fs mutations in #MSIH #colorectalcancer Fantastic computational work along with in vitro validation doi.org/10.1016/j.cell…

🍾 Very happy to announce that @AnaMBolivarA from the #VilarLab has been awarded a pre-doc fellowship @NIH T32 Training Program in Translational Genomics & Precision Medicine Approaches in Cancer Congrats!! Very proud of you


📢 Welcome @cemdede Cem is joining the #VilarLab for his first PhD rotation @MDA_UTHGrad Looking forward to working with you for the following weeks!


📚#VilarLab #JournalClub Today Nejla Lermi Ozirmak is presenting the work from @VeroushkaBalle1 @DrJohnKisiel @FASinicropeMD Very promising data for development of future early diagnostic tools in #LynchSyndrome pubmed.ncbi.nlm.nih.gov/33350853/

evilarsan's tweet image. 📚#VilarLab #JournalClub Today Nejla Lermi Ozirmak is presenting the work from @VeroushkaBalle1 @DrJohnKisiel @FASinicropeMD Very promising data for development of future early diagnostic tools in #LynchSyndrome pubmed.ncbi.nlm.nih.gov/33350853/

Loading...

Something went wrong.


Something went wrong.